N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide

C154H167F9N30O12 — CID 158211937

IUPACN-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
SMILESCCCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1F.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(Cc5c(F)cccc5F)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(Cc5c(F)cccc5F)C4)cc23)ccn1
InChIInChI=1S/C32H37FN6O3.C31H31F3N6O2.C31H34F2N6O2.C31H35FN6O3.C29H30F2N6O2/c1-5-15-38(3)32(41)28-12-10-23(18-39(28)19-25-26(33)7-6-8-29(25)42-4)35-31(40)22-9-11-27-24(17-22)30(37-36-27)21-13-14-34-20(2)16-21;1-18-12-19(10-11-35-18)28-22-13-20(6-8-26(22)37-38-28)29(41)36-21-7-9-27(30(42)40-16-31(2,34)17-40)39(14-21)15-23-24(32)4-3-5-25(23)33;1-4-38(5-2)31(41)28-12-10-22(17-39(28)18-24-25(32)7-6-8-26(24)33)35-30(40)21-9-11-27-23(16-21)29(37-36-27)20-13-14-34-19(3)15-20;1-5-37(3)31(40)27-12-10-22(17-38(27)18-24-25(32)7-6-8-28(24)41-4)34-30(39)21-9-11-26-23(16-21)29(36-35-26)20-13-14-33-19(2)15-20;1-17-13-18(11-12-32-17)27-21-14-19(7-9-25(21)34-35-27)28(38)33-20-8-10-26(29(39)36(2)3)37(15-20)16-22-23(30)5-4-6-24(22)31/h6-9,11,13-14,16-17,23,28H,5,10,12,15,18-19H2,1-4H3,(H,35,40)(H,36,37);3-6,8,10-13,21,27H,7,9,14-17H2,1-2H3,(H,36,41)(H,37,38);6-9,11,13-16,22,28H,4-5,10,12,17-18H2,1-3H3,(H,35,40)(H,36,37);6-9,11,13-16,22,27H,5,10,12,17-18H2,1-4H3,(H,34,39)(H,35,36);4-7,9,11-14,20,26H,8,10,15-16H2,1-3H3,(H,33,38)(H,34,35)/t23-,28+;21-,27+;22-,28+;22-,27+;20-,26+/m11111/s1
InChIKeyGCELIJSQAQLWLZ-UMKDQFCYSA-N
MW2801.21 g/mol
LogP22.49
Rot. Bonds37

About N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide

N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide (PubChem CID 158211937) has the molecular formula C154H167F9N30O12 and a molecular weight of 2801.21 g/mol. Its IUPAC name is N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide.

Molecular Properties

Compound NameN-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
PubChem CID158211937
Molecular FormulaC154H167F9N30O12
Molecular Weight2801.21 g/mol
Exact Mass2799.32
IUPAC NameN-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
SMILESCCCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1F.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(Cc5c(F)cccc5F)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(Cc5c(F)cccc5F)C4)cc23)ccn1
InChIInChI=1S/C32H37FN6O3.C31H31F3N6O2.C31H34F2N6O2.C31H35FN6O3.C29H30F2N6O2/c1-5-15-38(3)32(41)28-12-10-23(18-39(28)19-25-26(33)7-6-8-29(25)42-4)35-31(40)22-9-11-27-24(17-22)30(37-36-27)21-13-14-34-20(2)16-21;1-18-12-19(10-11-35-18)28-22-13-20(6-8-26(22)37-38-28)29(41)36-21-7-9-27(30(42)40-16-31(2,34)17-40)39(14-21)15-23-24(32)4-3-5-25(23)33;1-4-38(5-2)31(41)28-12-10-22(17-39(28)18-24-25(32)7-6-8-26(24)33)35-30(40)21-9-11-27-23(16-21)29(37-36-27)20-13-14-34-19(3)15-20;1-5-37(3)31(40)27-12-10-22(17-38(27)18-24-25(32)7-6-8-28(24)41-4)34-30(39)21-9-11-26-23(16-21)29(36-35-26)20-13-14-33-19(2)15-20;1-17-13-18(11-12-32-17)27-21-14-19(7-9-25(21)34-35-27)28(38)33-20-8-10-26(29(39)36(2)3)37(15-20)16-22-23(30)5-4-6-24(22)31/h6-9,11,13-14,16-17,23,28H,5,10,12,15,18-19H2,1-4H3,(H,35,40)(H,36,37);3-6,8,10-13,21,27H,7,9,14-17H2,1-2H3,(H,36,41)(H,37,38);6-9,11,13-16,22,28H,4-5,10,12,17-18H2,1-3H3,(H,35,40)(H,36,37);6-9,11,13-16,22,27H,5,10,12,17-18H2,1-4H3,(H,34,39)(H,35,36);4-7,9,11-14,20,26H,8,10,15-16H2,1-3H3,(H,33,38)(H,34,35)/t23-,28+;21-,27+;22-,28+;22-,27+;20-,26+/m11111/s1
InChIKeyGCELIJSQAQLWLZ-UMKDQFCYSA-N
XLogP22.49
TPSA489.56 Ų
H-Bond Donors10
H-Bond Acceptors27
Rotatable Bonds37
Heavy Atoms205
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002801.21
LogP ≤ 522.49
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1027

Analyze N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(3R,5R)-1-[(2-fluoro-6-methoxyphenyl)methyl]-5-methylpiperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591155
N-[(3S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-oxopiperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591179
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(3-hydroxy-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591315
N-[(3R,6S)-6-[cyclopropyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591316
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[(1-methylcyclopropyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591337
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[[1-(hydroxymethyl)cyclopentyl]methylcarbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591338
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(4-hydroxypiperidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591339
N-[(3R,6S)-6-(4,4-difluoropiperidine-1-carbonyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide
CID 56591359
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(pyrrolidine-1-carbonyl)piperidin-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide
CID 56591360
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(morpholine-4-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591361
N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591380
N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(hydrazinecarbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
CID 56591383

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The IUPAC name of N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide (CID 158211937) is N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide.
What is the SMILES notation for N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The canonical SMILES for N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide is CCCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(C)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1OC.CCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1Cc1c(F)cccc1F.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(Cc5c(F)cccc5F)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(Cc5c(F)cccc5F)C4)cc23)ccn1.
What is the InChIKey of N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The InChIKey is GCELIJSQAQLWLZ-UMKDQFCYSA-N. The full InChI is InChI=1S/C32H37FN6O3.C31H31F3N6O2.C31H34F2N6O2.C31H35FN6O3.C29H30F2N6O2/c1-5-15-38(3)32(41)28-12-10-23(18-39(28)19-25-26(33)7-6-8-29(25)42-4)35-31(40)22-9-11-27-24(17-22)30(37-36-27)21-13-14-34-20(2)16-21;1-18-12-19(10-11-35-18)28-22-13-20(6-8-26(22)37-38-28)29(41)36-21-7-9-27(30(42)40-16-31(2,34)17-40)39(14-21)15-23-24(32)4-3-5-25(23)33;1-4-38(5-2)31(41)28-12-10-22(17-39(28)18-24-25(32)7-6-8-26(24)33)35-30(40)21-9-11-27-23(16-21)29(37-36-27)20-13-14-34-19(3)15-20;1-5-37(3)31(40)27-12-10-22(17-38(27)18-24-25(32)7-6-8-28(24)41-4)34-30(39)21-9-11-26-23(16-21)29(36-35-26)20-13-14-33-19(2)15-20;1-17-13-18(11-12-32-17)27-21-14-19(7-9-25(21)34-35-27)28(38)33-20-8-10-26(29(39)36(2)3)37(15-20)16-22-23(30)5-4-6-24(22)31/h6-9,11,13-14,16-17,23,28H,5,10,12,15,18-19H2,1-4H3,(H,35,40)(H,36,37);3-6,8,10-13,21,27H,7,9,14-17H2,1-2H3,(H,36,41)(H,37,38);6-9,11,13-16,22,28H,4-5,10,12,17-18H2,1-3H3,(H,35,40)(H,36,37);6-9,11,13-16,22,27H,5,10,12,17-18H2,1-4H3,(H,34,39)(H,35,36);4-7,9,11-14,20,26H,8,10,15-16H2,1-3H3,(H,33,38)(H,34,35)/t23-,28+;21-,27+;22-,28+;22-,27+;20-,26+/m11111/s1.
What are the key properties of N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide has a molecular weight of 2801.21 g/mol, XLogP of 22.49, 37 rotatable bonds, 10 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6S)-6-(diethylcarbamoyl)-1-[(2,6-difluorophenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(dimethylcarbamoyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2,6-difluorophenyl)methyl]-6-(3-fluoro-3-methylazetidine-1-carbonyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-[ethyl(methyl)carbamoyl]-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-[methyl(propyl)carbamoyl]piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide is sourced from PubChem (CID 158211937), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).